165 related articles for article (PubMed ID: 32407908)
1. Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy.
Rabasté S; Cobo-Calvo A; Nistiriuc-Muntean V; Vukusic S; Marignier R; Cotton F;
J Neuroradiol; 2021 Feb; 48(1):28-36. PubMed ID: 32407908
[TBL] [Abstract][Full Text] [Related]
2. Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD.
Hyun JW; Lee HL; Park J; Kim J; Min JH; Kim BJ; Kim SW; Shin HY; Huh SY; Kim W; Seo JW; Kim KH; Kim SH; Kim HJ
Mult Scler; 2022 May; 28(6):989-992. PubMed ID: 34865555
[TBL] [Abstract][Full Text] [Related]
3. Bright spotty lesions as an imaging marker for neuromyelitis optica spectrum disorder.
Salama S; Levy M
Mult Scler; 2022 Oct; 28(11):1663-1666. PubMed ID: 33635151
[TBL] [Abstract][Full Text] [Related]
4. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
5. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.
Zalewski NL; Morris PP; Weinshenker BG; Lucchinetti CF; Guo Y; Pittock SJ; Krecke KN; Kaufmann TJ; Wingerchuk DM; Kumar N; Flanagan EP
J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):218-225. PubMed ID: 27913626
[TBL] [Abstract][Full Text] [Related]
6. MRI Features of Aquaporin-4 Antibody-Positive Longitudinally Extensive Transverse Myelitis: Insights into the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
Chee CG; Park KS; Lee JW; Ahn HW; Lee E; Kang Y; Kang HS
AJNR Am J Neuroradiol; 2018 Apr; 39(4):782-787. PubMed ID: 29449281
[TBL] [Abstract][Full Text] [Related]
7. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
Chien C; Scheel M; Schmitz-Hübsch T; Borisow N; Ruprecht K; Bellmann-Strobl J; Paul F; Brandt AU
Mult Scler; 2019 Dec; 25(14):1926-1936. PubMed ID: 30475082
[TBL] [Abstract][Full Text] [Related]
8. Identifying specific myelopathy etiologies in the evaluation of suspected myelitis: A retrospective analysis.
Alkabie S; Casserly CS; Morrow SA; Racosta JM
J Neurol Sci; 2023 Jul; 450():120677. PubMed ID: 37207546
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
10. "Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
Yonezu T; Ito S; Mori M; Ogawa Y; Makino T; Uzawa A; Kuwabara S
Mult Scler; 2014 Mar; 20(3):331-7. PubMed ID: 23828869
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica spectrum disorders with and without connective tissue disorders.
Yang CS; Zhang QX; Chang SH; Zhang LJ; Li LM; Qi Y; Wang J; Sun ZH; Zhangning N; Yang L; Shi FD
BMC Neurol; 2018 Oct; 18(1):177. PubMed ID: 30355349
[TBL] [Abstract][Full Text] [Related]
13. Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.
Hsu JL; Liao MF; Chang KH; Cheng MY; Ro LS
BMC Neurol; 2021 Apr; 21(1):153. PubMed ID: 33836682
[TBL] [Abstract][Full Text] [Related]
14. MRI differences between MOG antibody disease and AQP4 NMOSD.
Salama S; Khan M; Shanechi A; Levy M; Izbudak I
Mult Scler; 2020 Dec; 26(14):1854-1865. PubMed ID: 31937191
[TBL] [Abstract][Full Text] [Related]
15. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
Sechi E; Krecke KN; Messina SA; Buciuc M; Pittock SJ; Chen JJ; Weinshenker BG; Lopez-Chiriboga AS; Lucchinetti CF; Zalewski NL; Tillema JM; Kunchok A; Monaco S; Morris PP; Fryer JP; Nguyen A; Greenwood T; Syc-Mazurek SB; Keegan BM; Flanagan EP
Neurology; 2021 Sep; 97(11):e1097-e1109. PubMed ID: 34261784
[TBL] [Abstract][Full Text] [Related]
16. [Actual issues of serum aquaporin-4 autoantibodies evaluation in the diagnostics of neuromyelitis optica spectrum disorders].
Krasnov VS; Totolyan NA; Nazarov VD; Mazing AV; Makshakov GS; Lapin SV; Evdoshenko EP; Skoromets AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):24-31. PubMed ID: 32844626
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
[TBL] [Abstract][Full Text] [Related]
18. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
20. Early and extensive spinal white matter involvement in neuromyelitis optica.
Hayashida S; Masaki K; Yonekawa T; Suzuki SO; Hiwatashi A; Matsushita T; Watanabe M; Yamasaki R; Suenaga T; Iwaki T; Murai H; Kira JI
Brain Pathol; 2017 May; 27(3):249-265. PubMed ID: 27082714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]